How many clinical-trial readouts are scheduled for June 2027?

pdufa.bio currently tracks 48 clinical-trial readouts with dates in June 2027, each linked to a primary source. The list updates as new filings appear and dates shift.

What is a clinical-trial readout date?

A readout date is the estimated time a trial reports topline results, based on its registered primary-completion date; these are estimates and shift.

Does pdufa.bio predict whether these will be approved?

No. We do not publish per-drug approval probabilities. We provide the verified facts, primary-source links, and historical base rates so you can judge for yourself.

pdufa.bio

Calendar Decisions Readouts Run-up Stocks

Drug Index Conferences Advisory Committees Screener Research API SLS tracker Account

Pro

Home › Readouts › June 2027

June 2027 clinical-trial readouts

Updated August 7, 2026·next FDA decision on the calendar

trial-readout estimates for June 2027, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.

← May 2027 July 2027 →

15 readouts

AVLN · Jun 2027 (est.)

AP01: Pulmonary Fibrosis

Awaiting data

KYMR · Jun 2027 (est.)

KT-621: Atopic Dermatitis

Awaiting data

FDMT · Jun 2027 (est.)

4D-150 IVT: Macular Neovascularization Secondary to Age-Related Macular Degeneration

Awaiting data

FTH · Jun 2027 (est.)

SNS-101: Solid Tumor, Adult

Awaiting dataupdated 10mo ago

IMMP · Jun 2027 (est.)

eftilagimod alfa: Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Awaiting data

IONS · Jun 2027 (est.)

Olezarsen: Familial Chylomicronemia Syndrome

JAZZ · Jun 2027 (est.)

CPX-351: Acute Myeloid Leukemia

KYTX · Jun 2027 (est.)

Standard of Care Treatment: Rheumatoid Arthritis

Awaiting dataupdated 4mo ago

SVRA · Jun 2027 (est.)

Molgramostim: Autoimmune Pulmonary Alveolar Proteinosis

LNTH · Jun 2027 (est.)

PI-2620: Alzheimer Disease

NMRA · Jun 2027 (est.)

NMRA-335140: Major Depressive Disorder

Awaiting data

NVS · Jun 2027 (est.)

Remibrutinib: Hidradenitis Suppurativa

SMMT · Jun 2027 (est.)

Ivonescimab: Thymus Carcinoma

BLTE · Jun 2027 (est.)

Tinlarebant: Geographic Atrophy

Awaiting dataupdated 6mo ago

INDP · Jun 2027 (est.)

Decoy20: Solid Tumor, Adult

Awaiting dataupdated 5mo ago

Looking for an approval probability for these? We deliberately don't publish one. Here's why, and what we show instead (verified history + base rates).